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Abstract 
Hemopoietic system derived progenitor cells with mesenchymal features have been identified 
including CD14
+ monocyte-derived progenitors. However, it is unclear whether there are 
mesenchyme derived progenitors with hematopoietic potential. Herein, we identified a novel 
CD14
- cell-derived population with both mesenchymal and hematopoietic features in rat 
peripheral blood, and this cell population is different from the CD14
+ monocyte-derived 
progenitors  but  designated  peripheral  blood  multipotential  mesenchymal  progenitors 
(PBMMPs). Phenotype analysis demonstrated   e x p r e s s i o n   o f   m e s e n c h y m a l   m a r k e r s   i n   P B M M P s  
including BMPRs, Endoglin/CD105, Fibronectin (Fn), Vimentin (Vim), Collagen (Col) I/II/III 
along with hematopoietic marker CD34. CD14
+ cell-derived population shared the same 
characteristics with CFs. In mixed culture of CD14
+ and CD14
- cells ,   P B M M P s   w e r e   a   p r e-
dominant component and expressed CD29
high,   C D 7 3
high,   C D 3 4
high,   C D 4 5
low and CD90. Except 
f o r   t h e   v a l u e   o f   m i x e d   T   l y m p h o c y t e s   a n d   C D 1 4
+ cell-derived population, hematopoietic 
characters of cultured PBMMPs were indicated by CD14
-/CD34
+/CD45
-/CD90
+. The me-
senc h y m a l   o r i g i n   w a s   f u r t h e r   c o n f i r m e d   b y   c o m p a r i n g   P B M M P s   w i t h   b o n e   m a r r o w   s t r o m a l  
cells. Finally, we transplanted PBMMPs into a skin wound model, and results showed the 
specific potential of PBMMPs in not only extracellular matrix secretion but epidermal rege-
neration. This study provides evidence that peripheral blood contains common hemato-
poietic-mesenchymal progenitors from both hematopoietic and mesenchymal lineages, and 
CD34
+ mesenchymal progenitors  are  a  possible  alternative  source  of  epidermal  cells  in 
wound healing. 
Key words: Peripheral blood stem cells; Mesenchymal stem cells; Hemopoietic stem cells; Stem cell 
plasticity; Common progenitor; Wound healing 
Introduction 
Adult  bone  marrow  shelters  different  types  of 
stem cells, including hematopoietic and mesenchymal 
stem  cells  [1-3].  If  bone  marrow-derived  stem  cells 
play a role in the regeneration a n d   r e p a i r   o f   peripheral 
organ and tissues, transmission of these cells through 
blood is t o   b e   e xpected. I t   h a s   b e e n   p r o v e n that at least 
two kinds of adherent cells are isolated  from  the pe-
ripheral blood to  date:  One  is circulating fibrocytes Int. J. Med. Sci. 2011, 8 
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(CFs),  which  represent  hematopoietic  origin 
(CD11b+/CD34+/CD45+/Collgen-I+),  have  mul-
ti-differentiation potency and are involved in wound 
healing  [4-6],  and  the  other  is  peripheral 
blood-derived  mesenchy m a l   s t e m   c e l l s   ( PBMSCs), 
which  have  characteristics  of  mesenchymal  lineage 
(CD34-/CD45-/CD29+/CD44+/CD73+/CD90+)  and 
are  similar  to  bone  marrow  stromal  cells  (BMSCs) 
[7,8]. 
Mesenchymal stem cells (MSCs) are identified as 
adherent fibroblast-like cells in t h e   b o n e   m a r r o w   t h a t  
can differentiate into mesenchymal tissues, including 
bone, cartilage, fat, muscle, and bone marrow stroma 
[9]. Recently, mesenchymal progenitors having simi-
larities in m o r p h o l o g i c   a n d   p h e n o t y p i c   f e a t u r e s   a n d  
differentiation potentials to MSCs have been reported 
at extremely low frequencies in umbilical cord blood 
a s   w e l l   a s   i n   f e t a l   a n d   a d u l t   p e r i p h e r a l   b l o o d   [ 10-12]. 
MSCs and MSC-like cells  in peripheral blood do not 
express  hematopoietic  markers  or  the  stem 
cell/endothelial  cell  marker  CD34  [9-12].  However, 
the attempts to demonstrate PBMSCs have been un-
rewarding, except for a report of Fernandez et al, who 
identified  cells  with  the  features  of  MSCs  in 
growth-factor-mobilized  peripheral  blood  cells  of 
breast cancer patients [13]. Several studies have iso-
lated PBMSCs using the culture conditions similar to 
t h o s e   d e f i n e d   f o r   B M S C s ,   w h i c h   s u p p o r t s  the  exis-
tence of a small population of circulating MSCs. But 
the  isolation of these cells is obviously difficult and 
these cells are subject to variation depending on the 
methods for isolation and sorting of peripheral blood 
mononuclear  cells  (PBMCs),  and  on  culture  condi-
tions [12-16]. 
We have used the skin wound pretreatment to 
m o b i l i z e   M S C s   f r o m   t h e   b o n e   m a r r o w   t o   t h e   p e r i-
pheral blood and BMSCs’ culture supernatant served 
as condition medium to induce PBMSCs’ differentia-
tion  (unpublished  data).  In  the  absence  of  external 
influence, a population of CD14- mesenchymal cells 
with hematopoietic potential was harvested. Howev-
er,  whether  this  population is derived from mesen-
c h y m a l   o r   h e m a t o p o i e t i c   l i n e a g e   i s   s t i l l   u n c l e a r .   I n   t h i s  
study, we analyzed the characteristics of cells derived from 
CD14+  and CD14-  populations,  and  results  showed 
the CD14- cell derived population h a d   b o t h   m e s e n-
chymal and hematopoietic features and was different 
f r o m   t h e   C D 1 4 +  monocyte-derived  progenitors.  We 
designated  this  cell  population as  peripheral  blood 
multipotential mesenchymal progenitors (PBMMPs). 
CD14+ cell-derived population shared the same cha-
racteristics with CFs and its mesenchymal origin was 
f u r t h e r   c o n f i r m e d   b y   c o m p a r i n g   P B M M P s   w i t h  
BMSCs. Finally, we transplanted PBMMPs into a skin 
wound  model,  and  results  showed  the  PBMMPs 
could  not  only  secret  extracellular  matrix  secretion, 
but  also  induce  epidermal  regeneration.  Our  study 
provides  evidence  that  blood  contains  common  he-
matopoietic-mesenchymal  progenitors  from  both  li-
neages, and CD34+  mesenchymal  progenitors are a 
possible  alternative  source  of  epidermal  cells  in 
wound healing.  
Materials and methods 
Cell Culture 
A l l   a n i m a l   p r o c e d u r e s   a r e   a p p r o v e d   b y   t h e   r e-
sponsible  Animal  Care  and  Use  Committee  of  the 
Fourth  Military  Medical  University.  Blood  samples 
w e r e   o b t a i n e d   f r o m   t h e   j u g u l a r   v e i n   o f   S D   r a t s   a g e d   8  
weeks and weighing about 220 g and bone marrow 
was as p i r a t e d   f r o m   t h e   t i b i a   a n d   f e m u r   o f   2 -week-old 
S D   r a t s .   A b o u t   5 -m l   b l o o d   a n d   b o n e   m a r r o w   w e r e  
anti-c o a g u l a t e d   b y   h e p a r i n   i n   t u b e s .   F o l l o w i n g   b e i n g  
m i x e d   w i t h   s a m e   v o l u m e   o f   p h o s p h a t e -buffered  sa-
line  (PBS),  the  samples  were  added  onto  7-ml  Per-
coll-P a q u e   ( 1 .083 g/ml; GE Healthcare, UK) in a 15-ml 
tube. Centrifugation was performed at 2,100 rpm for 
20 min. The cells in the interface layer were collected 
into another 15-m l   t u b e ,   w a s h e d   t w i c e   w i t h   P B S ,   a n d  
c o u n t e d   a f t e r w a r d s   u n d e r   a   l i g h t   m i c r o s c o p e .   A f t e r   a n  
additional wash with PBS, PBMCs were re-suspended 
in  Dulbecco’s  modified  Eagles  medium  (DMEM) 
containing 10% FCS (Gibco, USA), 100 IU/ml penicil-
lin and 100 μg/ml streptomycin (Sigma, USA), seeded 
a t   a   d e n s i t y   o f   2 ×106  cells/ml in a T25 flask and 
grown in the absence of additional growth factors at 
3 7 ° C   i n   a   h u m i d i f i e d   a t m o s p h e r e   o f   9 5 %   a i r   a n d   5 %  
CO2. The medium was replaced every 3 days. When 
the  cell  confluence  reached  80%,  cells  were  trypsi-
nized,  re-seeded  in  new  T75 flasks  and  maintained 
under  the  same  culture  condition.  C e l l s   a t   t h e   3 rd 
passage  were  collected  and  used  for  the  following 
assays. 
CFs  were  isolated  from  human  Leukopaks 
(Blood Center of Fourth Military Medical University, 
Xi’an)  by  Percoll-Paque  density  gradient  centrifuga-
tion (1.073 g/ml) and grown under the same condi-
tion.  When  the  fibroblast-like  cells  were  observed, 
macrophage  colony-stimulating  factor  (M-CSF)  was 
added at a final concentration of 50 ng/ml.  
Immunomagnetic Selection and Cell Interaction 
Initially isolated cells were a hybrid system and 
t h e   o r i g i n   o f   P B M M P s   w a s   n o t   c l e a r .  Therefore, the 
total PBMCs prepared from each animal were frac-
tionated by immunomagnetic selection of monocytes 
using  anti-rat  CD14 antibody  attached to Dynabeads 
followed by in vitro culture of each fraction. Enriched Int. J. Med. Sci. 2011, 8 
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preparations were verified to be above 98% in purity 
by CD14 staining as determined by flow cytometry. 
Because CD14+ c e l l s   a c c o u n t e d   f o r   a b o u t   o n e   t e n t h   o f  
CD14- c e l l s   a n d   t h e   i s o l a t i o n   w a s   p e r f o r m e d   w i t h   a  
very small number of seeded ce l l s .   W e   s e t   1 0 5 cells 
and 106 cells as one unit, respectively, which is a con-
dition more close to normal composition and helps to 
s t u d y   t h e   i n t e r a c t i o n   b e t w e e n   t w o   k i n d s   o f   c e l l s   a n d  
count the clone numbers instead of percentage. Using 
the  Millicell  co-culture  system  (0.4  μm;  Millipore, 
USA),  one  unit  of  CD14+  or  CD14-  cells was  main-
tained i n   e i t h e r   t h e   u p p e r   o r   the  lower chamber of 
24-well  plate.   A f t e r   7   d a y s   of  culture,  clones  (cells 
which relatively centralized and had a clear margin 
were  also  considered  as  one  clone)  growing  in  the 
lower  chamber were  counted. I n   t h e   m i x e d   c u l t u r e ,  
CD14+  and  CD14-  cells  with  different  units  were 
seeded in 6-well plate at the ratio of 1:1, 1:2, 1:3, 1:4 
and 1:5 to observe the clone formation. 
In  order  to  preliminarily  investigate   t h e   r e-
quirement of T lymphocytes in PBMMPs’ differentia-
tion, CD14- cells were seeded in 6-well plate and the 
non-adherent cells (presumably T lymphocytes) were 
r e m o v e d   b y   w a s h i n g   w i t h   P B S   3 ~ 5   t i m e s   3   d a y s   l a t e r .  
The adherent cells were further maintained for 7 days 
and observed under an inverted light microscope. 
RT-PCR 
Total  RNA  was  extracted  from  PBMMPs  and 
BMSCs  using  the  RNeasy  extraction  kit  (Invitrogen, 
U S A )   a n d   g e n o m i c   D N A   w a s   r e m o v e d   b y   D N a s e   I ,  
according  to  the  manufacturer’s  instrucctions. 
First-strand  cDNA  synthesis  and  PCR  were  per-
formed as described previously [6]. The primers were 
as follows: β-actin: 5’-T G G   A A T   C C T   G T G   G C A   T C C  
ATG AAA C-3’ (Forward);  5’-TAA  AAC  GCA  GCT 
C A G   T A A   C A G   T C C   G -3’ (Reverse); Collagen (Col)-I: 
5’-GGA  GAG  TAC  TGG  ATC  GAC  CCT  AAC-3’ 
(Forward); 5’-CTG ACC TGT CTC CAT GTT GCA-3’ 
(Reverse); Col-III: 5’-GAA AAA ACC CTG CTC GGA 
ATT-3’ (Forward); 5’-GGA TCA ACC CAG TAT TCT 
CCA  CTCT-3’  (Reverse).  The  PCR  conditions  in-
cluded  predenaturation  at  94℃  for  2  min,  and  35 
cycles of denaturation at 94℃ for 45 sec, annealing at 
57℃ for  45 sec and extention  at  72℃ for  60 sec fol-
lowed by a final  extention  at  72℃  f o r   1 0   m i n .   T h e  
products  were  subjected  to  1%  agarose  gel  electro-
phoresis.  
Phenotype Analysis 
PBMMP and  BMSCs  were sub-cultured on ste-
rile  cover-slips  overnight  for  adherence.  Following 
w a s h i n g   w i t h   P B S ,  a fraction of cells were fixed in cool 
acetone  for  10  min  at  room  temperature  and  incu-
bated  with  one  of  the  following  rabbit  pAbs:  an-
ti-B M P R   I A ,   a n t i -BMPR  II,  anti-Endoglin/CD105 
( 1 : 1 0 0 ;   S a n t a   c r u z ,   U S A ) ,   m o u s e   m A b s :   a n t i -Col  I 
(1:400; abcam, UK), anti-Col II (1:1000; Thermo, USA) 
and goat mAb: anti-CD34 (1:100; RnD, USA) over-
night at 4℃. Then, these cells were incubated  for  60 
min with FITC-conjugated goat  anti-rabbit,  goat  an-
ti-m o u s e   I g G   a n d   r a b b i t   a n t i -goat IgG (1:100; Santa 
cruz, USA), independently. The remaining cells were 
fixed  in  formaldehyde for 10 min at room tempera-
ture,  a n d   t h e   e n d o g e n e o u s   p e r o x i d a s e   a c t i v i t y   w a s  
quenched with 0.3% hydrogen peroxide for 15  min. 
Cells were then  incubated with one of the following 
mouse  mAbs: anti-Fibronectin  (Fn)  (0.1  µg/ml), an-
ti-Vimentin  (Vim)  (5  µg/ml;  Chemicon,  USA)  and 
α-smooth  muscle  actin  (SMA)  (1:100;  Santa  cruz) 
overnight  at  4℃ followed  by  treatment  with  second 
antibody. Visualization was performed using REAL™ 
EnVision™ Detection System (DAKO, Denmark). The 
primary  antibody  w a s   r e p l a c e d   w i t h   P B S   serving 
negative control. 
For  flow  cytometry  analysis,  following  two 
washes, aliquots containing 105 cells of  mixture  and 
BMSCs  were incubated at 4℃ f o r   1   h   w i t h   1 0 0   μ l   of 
saturating concentration of mouse mAb against CD4, 
CD8b  (Biolegend,  USA),  CD73  (BD  Pharmingen, 
USA),  rabbit  pAb  against  CD14 (Santa cruz, USA), 
g o a t   m A b   against C D 3 4   ( R n D ,   U S A ) ,   F I T C -conjugated 
mouse  mAb  against  CD29,  CD45,  CD90  and 
PE-conjugated mouse mAb against CD26 (Biolegend, 
USA)  and  isotype-matched  control,  independently. 
Following two  washes,  these cells were incubated at 
4℃  for  another  h o u r   w i t h   1 0 0   μ l   F I T C -conjugated 
F(ab’)2  f r a g m e n t s   o f   m A b   against  mouse  IgG  and 
PE-conjugated  rabbit  pAb  against goat IgG (1:50) in 
2%  BSA/PBS  followed  by  washing  twice,  and 
re-suspended in PBS. Quantitative fluorescence anal-
ysis was performed using an FACS Calibur cytometer 
a n d   C e l l Q u e s t   s o f t w a r e   p r o g r a m   ( B e c t o n   D i c k i n s o n ,  
USA).  The  cell  number  (at least 10,000  cells) versus 
fluorescence intensity was  recorded in each sample. 
CFs was incubated with FITC-conjugated mouse mAb 
against CD11b, CD14, CD34, CD44, CD45 and CD90 
(eBioscience, USA) and analyzed with the same pro-
cedures. 
Cell Cycle Analysis 
PBMMPs and BMSCs were trypsinized, fixed in 
70% alcohol and analyzed for c e l l   c y c l e   b y   f l o w   c y-
tometry (Beckman Coulter, USA). 
Osteogenic and Adipogenic Induction 
PBMMPs  and  BMSCs  were  seeded  in  a  6-well 
plate at a density of 5×105 cells/well in basic medium Int. J. Med. Sci. 2011, 8 
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for 24 h to allow adherence. Then, the medium was 
replaced with osteogenic induction medium contain-
ing DMEM, 10% FCS, 0.1 μM dexamethasone, 10 mM 
β-glycerolphosphate  and  50  mg/L  ascor-
bate-2-phosphate, and adipogenic induction medium 
consisting DMEM, 10% FCS, 0.25 μM dexamethason, 
100 μM indomethacin, 0.5 mM 3-isobutyl methylxan-
thine and 10 mg/L insulin. Cells were maintained for 
2 weeks and media were replaced twice weekly. The 
mineralized nodules were stained with Alizarin Red S 
and  neutral  lipid  vacuoles  with  Oil-r e d   O   ( S i g m a ,  
USA).  
In Vivo Transplantation 
Immunotolerance  of  4~6-week  old  C57  female 
mice weighing  about 20  g was induced with a single 
abdominal  subcutaneous  injection  of  cyclophospha-
mide  (cyclo)  (200  mg/kg;  Hengrui,  China).  Seven 
days later, intraperitoneal injection (i.p.) of cyclo  (20 
mg/kg) in normal saline was performed thrice (once 
every other day). T h i s   m e t h o d   d e v e l o p e d   b y   o u r   d e-
partment  renders  the  transplanted  cells  to  maintain 
their most functions and remain for at least one month 
without being rejected (unpublished data). Animals 
were  anesthetized  with  0.1%  pentobarbital  sodium 
i.p. and  the  full-thickness  dorsal skin (1.5 cm in di-
ameter)  including  the  panniculus  carnosus  muscle 
was  excised.  PBMMPs labeled  with  fluorescent  dye 
PKH-26  (106  cells/  0.5  ml  physiological  saline  per 
mouse) were injected into the w o u n d   b e d   a n d   m a r g i n a l  
a r e a   w h i c h   w e r e   c o v e r e d   w i t h   a   s t e r i l e  
semi-permeable membrane (Tegaderm, 3M) followed 
by wound suturing to preserve humidity. The control 
mice  were  injected  only  with  an  equal  volume  of 
normal saline. 
Histological and Immunofluorescence analysis 
Paraffin embedded s e c t i o n s   ( 5   μ m   in thickness) 
were de-paraffined, hydrated, submitted to different 
antigen retrievals, and quenched for endogenous pe-
roxidase (3% H2O2 in PBS). Nonspecific staining was 
blocked with 10% goat serum. Immunoreactivity was 
detected using REAL™ EnVision™ Detection System. 
The sections were treated with mouse anti-C o l   I   m A b  
overnight at 4°C, and with appropriate secondary for 
1 h at 37°C. Sections were counterstained with hema-
toxylin,  dehydrated,  and  mounted.  Cryosections  (6 
μ m   t h i c k )   w e r e   f i x e d   w i t h   c o ol acetone and blocked 
with  serum.  The  primary antibody was mouse  an-
ti-C K 1 4   o r   C K 1 9   m Abs (1:100; abcam, UK). After in-
cubation  overnight,  TRITC-conjugated  goat  an-
ti-mouse  IgG  and  FITC-conjugated goat anti-mouse 
IgG were a d d e d   f o l l o w e d   b y   i n c u b a t i o n   a t   3 7 ℃ for 1 
h.  Finally,  Hoechst33342  was  used  for  counterstain-
ing. The sections of negative control were incubated 
with  PBS  as  primary  antibody.  Sections  were  then 
visualized under fluorescent microscope. 
Statistical analysis 
Comparisons  between  two  groups  were  tested 
for statistical significance with the independent sam-
ple  t  test  with  SPSS  version  13.0  statistic  software 
p a c k a g e .   A   v a l u e   o f   P < 0.05 was  considered  statisti-
cally significant.  
RESULTS 
PBMMPs are derived from CD14- but not CD14+ Cells, 
and CD14+ Cells Partly Inhibit PBMMPs’ Growth and 
Proliferation  
To  determine  the  origin  of  PBMMPs,   w e   a n a-
lyzed  the  growth  of  adherent  CD14+  and  CD14- 
PBMCs cultured  on  plastic.   I n   C D 1 4 - wells, when the 
fibroblast-like cells initially appeared after 2~3 days of 
culture,  cell  body  became  large  and  had  branches, 
showing  morphology of MSCs  (Fig.1A-a ) .   I n   C D 1 4 + 
wells, sm a l l   c l u s t e r s   o f   r o u n d   c e l l s   d e v e l o p e d   a n d  cell 
processes  were  found.  After  4~5  days  of  culture, 
spindle-shaped adherent cells made their appearance 
(Fig.1A-b).  I n   t h e   m i x e d   c u l t u r e ,   fibroblast  and 
stromal-like  adherent  cells  became the predominant 
cell type in this system (Fig.1A-c). These isolated cells 
h a d   a d h e r e n c e   t o   v a r i o u s   e x t e n t s ,   C D 1 4 + cell-derived 
population closely a d h e r e d   t o   p l a s t i c   a n d   w a s   d i f f i c u l t  
t o   t r y p s i n i z e ,   P B M M P s   a d h e r e d   l o o s e l y   a n d   t h o s e   i n  
the mixed culture had moderate adherence. In addi-
tion, lymphocytes could not be completely removed 
by washing gently. Therefore, the percentage of ad-
herent cells was not used as an index. 
Using  single  culture  and  Millicell  co-culture 
system, we examined the in vitro cellular requirements 
in  PBMMPs  clone  formation  from  CD14-  cells  and 
their  interaction  with  CD14+  cells  (Fig.1B).  When 
CD14+  and  CD14-  cells  were  maintained  indepen-
dently  for  1  week,  1  and  4  clones  in  average  were 
found in the wells. When the CD14+ cells were grown 
in  the  lower  chamber  and  CD14- cells  in  the  upper 
chamber for 1 week, no significant increase of clone 
numbers appeared in the lower chamber. Controver-
sially, about half of the clone numbers appeared in the 
lower chamber when the CD14- cells   w e r e   g r o w n   i n  
the  lower  chamber  and  CD14+  cells  in  the  upper 
chamber  for  1  week.  These  results  indicated  the 
growth and proliferation of CD14- cells were partly 
inhibited by CD14+ cells, but CD14- cells   d i d   n o t   d e f i-
nitely promote the amplification of CD14+ cells. Simi-
l a r   r e s u l t s   w e r e   o b t a i n e d   i n   t h e   m i x e d   c u l t u r e   e x p e-
riment (Fig.1C), in which when the ratio of CD14+ cells 
to CD14- cells was 1:1 (normal condition), 1:2 and 1:3 Int. J. Med. Sci. 2011, 8 
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(a slight increase in  CD14- cells), 
there  were  no  clone  observed, 
while when the ratio was above 
1:4  (a  significant  increase  in 
CD14- cells), clones were signifi-
cantly  increased.  Culture  was 
p e r f o r m e d   f o r   a b o u t   2   w e e k s ,   t h e  
adherent  PBMMPs  were  trypsi-
nized  for  flow  cytometry  when 
the cell confluence reached 80% 
(data not shown).  
 
 
Fig.1.  Origination  of  PBMMP  and 
interaction  with  monocytes. (A)  In 
CD14- wells, cell body became large 
and  extended  branches,  showing 
morphology  of  MSCs.  In  CD14+ 
wells,  adherent  cells  with  a  spin-
dle-shaped morphology made their 
appearance.  In  mixed  culture,  ad-
herent cells appearing fibroblast and 
stromal-like morphology became the 
predominant  cell  type.  (B)  CD14- 
cell  fraction  gives  rise  to  more 
clones in single culture, its growth 
and proliferation are partly inhibited 
by CD14+ cell fraction, but CD14- 
cell fraction doesn’t definitely sup-
port the amplification of CD14+ cell 
fraction in co-culture system (0.4 μ
m  pore  diameter).  (C)  When  the 
ratio  of  CD14+  cell  fraction  to 
CD14- cell fraction was equal to 1:4, 
cell clones were observed in mixed 
culture, and the clone number is in 
direct  proportion  to  the  ratio. 
(Magnification 100×) 
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PBMMPs Need Lymphocytes’ Support, and Express both 
Mesenchymal and Hematopoietic Features  
After  7  days  of  culture,  the  stromal-like  cells 
were  the  predominant  component  of  adherent  cells 
(Fig.2A-a,b) and the adherent cells could proliferate. 
F i v e   t o   t e n   d a y s ,   t h e r e   w a s   clone formation and the 
cells gradually conjugated (Fig.2A-c). When the sus-
pended  cells  (presumably  T  lymphocytes)  were  re-
moved as possible, cell proliferation terminated and 
karyopyknosis  and  fragmentation  occurred 
(Fig.2A-d). 
Based  on  the  mesenchymal  morphology, 
Col-I/III expressions were detected aiming to inves-
t i g a t e   t h e   r o l e   o f   P B M M P s   i n   t h e   w o u n d   h e a l i n g ,   a n d  
a n   a f f i r m a t i v e   r e s u l t   w a s   a c q u i r e d   u n d e r   t h e   c o n t r o l  
of  β-actin  (Fig.2B).  Then,  a  systematic  phenotypic 
characterization by immunofluorescence and  immu-
nohistochemistry  was  performed.  PBMMPs  were 
positive  for  mesenchymal  stem  cell  markers 
BMPR-IA,  BMPR-II  and  Endoglin  (CD105),  the  cy-
toskeletal  component  Vim,  the  fibroblast  products 
Col-I, Col-II and Fn, the myofibroblast marker α-SMA 
a n d   m o s t   i m p o r tantly, hematopoietic stem cell marker 
CD34 (Fig.2C). 
CD14+ Cell-derived Population Shares the Same Cha-
racters with CFs 
In  CD14+  cell  culture,  adherent  cells  appeared 
spindle-s h a p e d ,   a n d   s o m e   o f   t h e m   t r a n s f o r m e d   t o  
macrophage-like cells during culture (Fig.3A).  These 
cells  were  difficult  to  passage,  and  the  large  and 
r o u n d   c e l l s   b e c a m e   p r e d o m i n a n t   i n   t h e   l a t e   p e r i o d .  
T h e s e   f e a t u r e s   a r e   s i m i l a r   t o   t h o s e   o f   C F s ,   a   w e l l   r e c-
ognized hematopoietic derived progenitor cells with 
mesenchymal  features  (Fig.3B-a,b). Under  the  influ-
ence of M-CSF, CFs could maintain and proliferate for 
a long time (Fig.3B-c). CFs were difficult to proliferate 
and  passage  under  normal  condition,  and  macro-
phage-like cells spread in the disk for more than one 
month (Fig.3B-d). 
 
 
Fig.2. PBMMPs needs lymphocytes’ support, and expresses both mesenchymal andhematopoietic features. (A) After 7 days, 
stromal-like cells took the most parts of adherent cells (a,b). Clone formation in the ensuing 5～10 days cells (c). When 
floating cells (presumably T lymphocytes) were washed away as possible, cell proliferation ceased and karyopyknosis and 
fragmentation occurred (d). (B) Col-I/III genes expression under the control of β-actin was shown by RT-P C R .   ( C )   P B M M P  
w a s   p o s i t i v e   f o r   m e s e n c h y m a l   s t e m   c e l l   m a r k e r s   B M P R -IA, BMPR-II and Endoglin (CD105), the cytoskeletal component Vim, 
the fibroblast products Col-I ,   C o l -I I   a n d   F n ,   t h e  myofibroblast marker α-S M A   a n d   h e m a t o p o i e t i c   s t e m   c e l l   m a r k e r   C D 3 4   b y  
immunofluorescence and immunohistochemistry. (Magnification 100×) Int. J. Med. Sci. 2011, 8 
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Fig.3. CD14+ cell-derived population shares the same characters w i t h   C F s .   ( A )   A d h e r e n t   C D 1 4 +   c e l l s   a p p e a r e d   a   s p i n-
dle-shaped morphology, and some of them changed tomacrophage-like cells during culture. (B) CFs also appeared a spin-
dle-shaped morphology, it was maintained and proliferated by the incubation of G-CSF, and they transformed to macro-
phage-like cells without external stimulation f o r   m o r e   t h a n   o n e   m o n t h .   ( C )   Enhanced expression of CD34 from 2.99% to 
21.06% and CD45 from 96.8% to 9 8 . 9 2 %   i n   t h e   e a r l y   a n d   l a t e   p e r i o d   o f   p r i m a r y   c u l t u r e .   ( D )   C F s   a l s o   d i s p l a y e d   h e m a t o-
poietic markers CD11b (22.43%), CD14 (8.27%) and mesenchymal markers CD44 (99.03%), CD90 (57.59%). (Magnification 
40×, 100×) 
We  then  investigated  the  phenotypes  of  CFs, 
which  displayed  hematopoietic  markers 
CD11b/CD14low/CD34/CD45high/CD90  (Fig.3C,D) 
and  mesenchymal  markers  Col-I/Col-III/Fn/Vim 
( d a t a   n o t   s h o w n ) .   B e c a u s e   o f   d i f f i c u l t y   i n   p a s s a g i n g ,  
the expressions of hematopoietic markers CD34 and 
C D 4 5   i n   t h e   e a r l y   p e r i o d   w e r e   c o m p a r e d   w i t h   t h o s e   i n  
t h e   l a t e   p e r i o d   o f   p r i m a r y   c u l t u r e   ( F i g . 3 C ) .   R e s u l t s  
showed an enhanced expressions of CD34 (2.99% to 
21.06%) and CD45 (96.8% to 98.92%) (Fig.3C). These 
findings indicated the maturation of CFs, and the high 
expression of CD45 confirmed its hematopoietic ori-
g i n .   S i m i l a r   t o   t h i s ,   C D 1 4 + cell-derived population had 
a  decreased  CD14  expression,  increased  CD34  ex-
pression  and  high  expression  of  CD45  (data  not 
sho w n ) .   T h e s e   r e s u l t s   s u p p o r t   C D 1 4 +  cell-derived 
p o p u l a t i o n   i s   t h e   s a m e   c e l l   t y p e   o f   C F s   i n   r a t   b l o o d ,  
they are hematopoiesis-originated and share different 
characters  in  morphology,  proliferation,  differentia-
tion and phenotypes with PBMMPs. 
PBMMPs Are the Predominant Components in Mixed 
Culture, Shows an Enhanced Expression of CD34 but 
Maintained the Expressions of Mesenchymal Markers 
during Culture 
I n   t h e   l a t e   p h a s e   o f   p r i m a r y   m i x e d   c u l t u r e ,  
CD14-  cell-derived  fibroblast  and  stromal-like  cells 
o c c u p i e d   m o s t   o f   a r e a s   ( F i g . 4 A )   a n d   C D 1 4 + 
cell-derived  round  or  spindle-shaped  cells  were 
sparsely distributed,   t h e   c e l l s   a t   t h e   3 rd passage were 
universally fibroblast-like,  and  the  latter  ones  were 
scarcely found. These cells were passaged every 5~7 
days, up to a total of thirteen passages over 2 months. 
We analyzed the phenotypes of cells at 3rd passage in 
m i x e d   c u l t u r e   b y   f l o w   c y t o m e t r y .   L e s s   t h a n   2 0 %   o f  
c e l l s   w e r e   p o s i t i v e   f o r   T   l y m p h o c y t e   m a r k e r s   C D 4  
(11.5%),  CD8b  (19.8%)  and  CD26  (12.7%)  (also  ex-
pr e s s e d   i n   m a c r o p h a g e s )   a n d   a b o u t   7 0 %   w e r e   p o s i t i v e  
f o r   h e m a t o p o i e t i c   s t e m   c e l l   m a r k e r s   C D 3 4   ( 7 3 . 1 % )   a n d  
CD90 (69.5%). In addition, almost 100% of cells were 
positive for CD29 (100%) and CD73 (98.3%). Notably, 
cells  were  nearly  negative  for  the  mono-
cyte/macrophage  antigen  CD14  (2.0%)  and  only 
13.5% positive for CD45. In addition, 2.2% and 1.8% 
were  positive  FITC-  and  PE-conjugated  iso-
type-matched controls (Fig.4B). 
In comparison between the primary cells and the 
c e l l s   a t   3 rd p a s s a g e   i n   m i x e d   c u l t u r e ,   C D 3 4   e x pression 
was significantly increased (from 5.4% to 73.1%), but 
those of CD45 (from 2.9% to 13.5%) and CD90 (from 
55.4% to 69.5%) were slightly increased, and the ex-
pressions  of  CD14  (2.2%  and  2.0%),  mesenchymal 
markers CD29 (99.3% and 100%) and CD73 (97.9% 
and 98.3%)  remained  stable.  In addition,  1.2%  and 
2 . 0 %   o f   c e l l s   w e r e   p o s i t i v e   f o r   F I T C -  and 
PE-conjugated  isotype-matched  controls  in  primary 
culture (Fig.4C). These results demonstrate PBMMPs’ 
derivation from CD14- c e l l s   a n d   t h e i r   f e a t u r e s   o f   b o t h  
hematopoietic and mesenchymal stem cells. The en-
hanced  CD34  expression  indicates  their  maturation, 
a n d   t h e   s l i g h t l y   i n c r e a s e d   e x p r e s s i o n   o f   C D 4 5   d o e s n ’t 
support the hematopoietic origin of the predominant 
population in the culture. 
These results reveal that PBMMP s   a r e   t h e   p r e-
dominant population in the mixed culture although a 
s m a l l   a m o u n t   o f   T   l y m p h o c y t e s   a n d   m o n o-
cyte-derived CD34+/CD45+ progenitors are included, 
a n d   c e l l s   a f t e r   m o r e   t h a n   3   p a s s a g e s   c o u l d   b a s i c a l l y  
represent  the  characteristics  of  CD14-  cell-derived 
population. Considering the mesenchymal morphol-
ogy and phenotypes, we speculate the PBMMPs’ de-
rivation from mesenchymal lineage.  Int. J. Med. Sci. 2011, 8 
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Fig.4. PBMMP takes majority parts of mixed culture, shows an enhanced expression ofCD34 but maintained expression of 
mesenchymal markers during culture. (A) In the late phase of primary mixed culture, CD14- cell-derived fibroblast and 
stromal-like cells o c c u p i e d   t h e   m o s t   a r e a s .   ( B )   M i x e d   c e l l s   w e r e   p o s i t i v e   f o r   T   l y m p h o c y t e s   m a r k e r s   C D4 (11.5%), CD8b 
(19.8%), CD26 (12.7%) (also expressed in macrophage), hematopoietic stem cell markers CD34 (73.1%), CD90 (69.5%), 
hematopoietic marker CD45 (13.5%), msenchymal markers CD29 (100%), CD73  (98.3%),  and  negative  for  Mono-
cyte/macrophage antigen CD14 (2.0%). FITC- and PE-conjugated isotype-matched controls were positive in 2.2% and 1.8%. 
( C )   S i g n i f i c a n t   i n c r e a s e   o f   C D 3 4   e x p r e s s i o n   ( f r o m   5 . 4 %   t o   7 3 . 1 % ) ,   s l i g h t   i n c r e a s e   o f   C D 4 5   ( f r o m 2 . 9 %   t o   1 3 . 5 % )   a n d   C D 9 0  
(from 55.4% to 69.5%), maintained expression of CD14 (2.2% and2.0%), CD29 (99.3% and 100%) and CD73 (97.9% and 
98.3%) between the primary and 3rd passage of mixed culture. FITC- and PE-conjugated isotype-matched controls in 
primary culture were positive in 1.2% and 2.0%. (Magnification 40×, 100×) 
 Int. J. Med. Sci. 2011, 8 
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PBMMPs have Similar Morphology and Phenotypes to 
BMSCs 
The stromal-like morphology urges us to explore 
the  similarity  between  PBMMPs  and  BMSCs,  also 
known  as  bone  marrow  mesenchymal  stem  cells 
(BM-MSCs).  Just  like  the  m i x e d   c u l t u r e   o f   P B M C s ,  
B M S C s   a l s o   h a d   c e l l   p o p u l a t i o n s   d e r i v e d   f r o m   h e-
matopoietic and mesenchymal lineage, and hemato-
poiesis originated cells decreased by passaging. We 
c o m p a r e d   t h e s e   t w o   k i n d s   o f   c e l l s .   T h e   a p p e a r a n c e  
w a s   v e r y   s i m i l a r   a t   t h e   3 rd passage in clone formation 
and  cell  morphology  (Fig.5A),  and  BM-MSCs  had 
same  positive  staining  of 
BMPR-IA/BMPR-II/Endoglin  (CD105)/Col-I/Col-II 
(Fig.5B).  
 
 
Fig.5. PBMMP has similar morphology and phenotypes to BMSC s .   ( A )   T h e   a p p e a r a n c e   o f   P B M M P   a n d   B M S C s   w a s   v e r y   m u c h  
alike  at  the  3rd  passage  from  cloneformation  to  cell  morphology.  (B)  BMSCs  had  same  positive  staining  of 
BMPR-IA/BMPR-II/Endoglin (CD105)/Col-I/Col-I I w i t h   P B M M P .   ( C )   B M S C s   s h o w e d   p o s i t i v e   f o r   C D 4   ( 4 . 0 % ) ,   C D 8 b   ( 8 . 9 % )  
and CD26 (11.2%), negative for hematopoietic cell markers CD14 (2.3%), CD34 (0.7%), CD45 (0.9%), and highly positive 
forCD29 (93.9%), CD73 (88.5%) and CD90 (98.1%). FITC- and PE-conjugated isotype-matchedcontrols were positive in 
2.0% and 1.8%. (D) CD14 was stained positive in some culture of BMSCs mixed with monocytes. (E) Enhanced expression 
of CD45 is in relation to CD14, and CD34 expression maintained in the initial level indicated monocytes’ proliferation and 
they are CD34- in the primitive period, the way like that in peripheral blood. (Magnification 40×, 100×) 
 
Flow  cytometry  of  BMSCs  showed  cells  less 
p o s i t i v e   f o r   T   l y m p h o c y t e s   m a r k e r s   C D 4   ( 4 . 0 % ) ,   C D 8 b  
(8.9%)  and  CD26  (11.2%),  and  almost  negative  for 
hematopoietic cell markers CD14 (2.3%), CD34 (0.7%) 
a n d   C D 4 5   ( 0 . 9 % ) .   B u t   t h e s e   c e l l s   w e r e   s t r o n g   p o s i t i v e  
for CD29 (93.9%), CD73 (88.5%) and CD90 (98.1%). In 
addition,  2.0%  and  1.8%  of  cells  were  positive  for 
FITC-  and  PE-conjugated  isotype-matched  controls. 
( F i g . 5 C ) .   T h e s e   r e s u l t s   i n d i c a t e   t h e   d i f f e r e n t   p h e n o-
types  between  mixed  culture  (mainly  PBMMPs), 
BMSCs  have  hematopoietic cell markers CD34, and 
b o t h   B M S C s   a n d   P B M M P s   a r e   d e r i v e d   f r o m   C D 1 4 - 
progenitors. 
Enhanced Expression of CD45 is in relation to CD14 in 
BMSCs 
In culture of BMSCs mixed with hematopoietic 
stem cells, CD14 staining showed positive (Fig.5D). 
We  compared  hematopoietic  markers  CD14,  CD34 
a n d   C D 4 5   i n   t h e   p r i m a r y   c e l l s   a n d   c e l l s   a t   t h e   3 rd 
passage. Results showed the enhanced expression of 
C D 4 5   w a s   i n   r e l a t i o n   t o   C D 1 4 ,   a n d   C D 3 4   e x p r e s s i o n  
remains at the initial level. Positive staining for FITC- 
and  PE-conjugated  isotype-matched  controls  were 
f o u n d   i n   1 . 8 %   a n d   2 . 8 %   o f   p r i m a r y   c e l l s ,   1 . 5 %   a n d  
2.0% of cells at the 3rd passage (Fig.5E). These findings 
suggest enhanced expression of CD45 represents the 
proliferation of monocytes, and they are CD34- in the 
primitive period, which was similar to that in peri-
pheral blood. 
PBMMP has Increased Proliferation, Collagen Secretion and 
Similar Multi-differentiation Potential compared with 
BMSCs 
Expressions of Col-I and Col-III were detected in 
both kinds of cells, and results showed a seemly active Int. J. Med. Sci. 2011, 8 
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ability to secrete ECM of PBMMPs (Fig.6A). Cell cycle 
analysis showed the percent of PBMMP and  BMSCs 
in G2+S phase were 10.9 and 6.5, respectively, espe-
c i a l l y   t h e   p r o p o r t i o n   o f   P B M M P s  in S phase was 8.4, 
which was nearly doubl e   t o   t h a t   o f   B M S C s   i n   S phase 
(4.3) (Fig.6B). Analysis showed statistically significant 
difference  (P<0.05),  which  confirmed  a  significantly 
increased  proliferation  o f   P B M M P   c o m p a r e d   w i t h  
BMSCs (Fig.6C). 
When cultured under specific induction media, 
PBMMPs  possessed  osteogenic  and  adipogenic  po-
tentials and  were positive in Alizarin Red S and Oil 
red-O  staining (Fig.6D,  E). I n   o r d e r   t o   c o m p a r e   t h e  
multi-differentiation  potential  between  these  two 
groups, we randomly selected five fields to calculate 
th e   p e r c e n t a g e   o f   p o s i t i v e   a r e a   b y   I m a g e J   s o f t w a r e .  
Although the induction of BMSCs showed larger cal-
cium nodules and more lipid droplets, there were no 
statistically  significant  differences  (P>0.05),  which 
indicated a similar differentiation potential between 
PBMMPs and BMSCs (Fig.6F). 
 
 
Fig.6. PBMMP has more active proliferation, collagen secretion and similar multi-differentiation Potential compared with 
B M S C s .   ( A )   G e n e   e x p r e s s i o n   o f   C o l -I   a n d   C o l -III were detected in both kinds of cells, but it seemed like the production of 
Col-I I I   i n   P B M M P   w a s   m o r e   t h a n   t h a t   o f   B M S C s ,   w h i c h   i n d i c a t e s   a n   a c t i v e  a b i l i t y   t o   s e c r e t e   E C M   o f   P B M M P .   ( B )   R e p r e-
s e n t a t i v e   c e l l   c y c l e   a n a l y s i s   s h o w e d   t h e   p e r c e n t   o f   G 2 + S   p h a s e   i n   P B M M P   a n d   B M S C s  were 10.9 and 6.5 seperately, es-
pecially the percent of S phase in PBMMP was 8.4, nearly double to the percent of S phase in BMSCs (4.3). (C) The results 
of three tests were analyzed and showed a difference of statistical significance (P<0.05), which proved a more active pro-
liferation capability of PBMMP than BMSCs. (D) When cultured under specific induction media, PBMMP possessed os-
teogenic potential and stained positive by Alizarin Red S. (E) PBMMP also possessed adipogenic potential and stained positive 
by Oil red-O after induction. (F) Randomly selection of five fields to count the percentage of positive staining area by the 
software ImageJ and analyzed by spss13.0. Although the induction of BMSCs showed larger calcium nodules and more lipid 
droplets formation, there were no differences of statistical significance (P>0.05), which indicated similar differentiation 
potential of PBMMPs and BMSCs. (Magnification 200×) 
 
PBMMPs Accelerate Wound Repair through Collagen 
Deposition and Epithelialization 
On  the  10th  and  20th  day  after  transplantation, 
there  was  less  unclosed  wound  in  PBMMPs  group 
compared with control group (Fig.7A). We randomly 
selected five mice from each group, calculate the per-
centage of wound area by ImageJ software. Results 
showed a statistically significant difference in healing Int. J. Med. Sci. 2011, 8 
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r a t e   o n   t h e   1 0 th day, but not   o n   t h e   2 0 th day. Red flu-
orescence of PKH-2 6   i n   t h e   h e a l i n g   t i s s u e   s u g g e s t e d  
the survival of transplanted cells (Fig.7C).  
HE staining of the healing samples showed the 
number  of  regenerated  epidermal cells in  PBMMPs 
group  was larger than  that  in  control group.  These 
cells distributed uniformly in different layers, and the 
ridge became distinct in the epidermis. In the control 
group,  however,  a  few  epidermal  cells  were  found 
and  distributed  discontinuously  in  the  basal  layer, 
and  sparsely  distributed cells  were  observed in  the 
different  layer  without  any  ridges  (Fig.7D).  Strong 
staining  of  Col-I  in  the  dermis  indicates  PBMMPs’ 
differentiation into fibroblasts and secretion of a huge 
a m o u n t   o f   E C M   t o   f i l l   t h e   w o u n d ,   a n d   f u r t h e r   c o n-
firms their mesenchymal characteristics (Fig.7E) .   A f t e r  
immunofluorescence  staining,  we  found  positive 
staining of CK14 and CK19 in the basal membrane 
compartment, the epidermal layer and the surface of 
stratified epithelium (Fig.7F). These PBMMPs could 
differentiate into fibroblasts secreting ECM to heal the 
wound and into epithelial cells to participate in the 
re-epithelialization.  On  the  contrary,  there  were  not 
enough functional cells to repair the wound in control 
group, and thus intensified wound contraction, weak 
epithelialization and scar formation were found. 
 
 
Fig.7. PBMMP accelerates skin repair through collagen deposition and epithelialization. (A) O n   t h e   1 0 th and 20th day after 
transplantation, there was less unclosed wound in PBMMP group c o m p a r e d   w i t h   t h e   c o n t r o l   g r o u p .   ( B )   T h e r e   a r e   s t a t i s t i c a l  
differences of healing rate between PBMMP group and control group on the 10th day (P<0.05), but without statistical 
d i f f e r e n c e s   o n   t h e   2 0 t h   d a y   ( P > 0 . 0 5 )   ( n = 5 ) .   ( C )   R e d   f l u o r e s c e n c e   o f   P K H -26 detected in the healing tissue displayed the 
s u r v i v a l   o f   t h e  transplanted cells. (D) In PBMMP group, regenerated epidermal cells distributed uniformly in different layers 
and the ridge became distinct in epidermis. In control group, a few epidermal cells distributed discontinuously in the basal 
layer, scattered cells observed in the different layer and no ridges f o r m e d .   A l s o   a   l a r g e r   a m o u n t   o f   E C M   d e p o s i t i o n   w a s  
showed i n   P B M M P   g r o u p .   ( E )   Strong staining of Col-I in the dermis, which indicates PBMMP’s differentiating into fibroblasts 
and secreting a   h u g e   a m o u n t   o f   E C M   t o   f i l l   t h e   w o u n d .   ( F )  Positive staining of CK14 and CK19 in the basal membrane 
compartment, epidermallayer and the surface of stratified epithelium. (Magnification 100×, 200×) Int. J. Med. Sci. 2011, 8 
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Discussion 
O n e   o f   t h e   m o s t   i n t e r e s t i n g   f i n d i n g s   i n   t h i s   s t u d y  
is  that  CD14-  cell-derived  PBMMPs  appear  mesen-
chymal in morphology, phenotypes and gene expres-
sion, and have high expression of hematopoietic stem 
c e l l   m a r k e r   C D 3 4 .   T h i s   i s   t h e   f i r s t   s t u d y   s h o w i n g   m e-
senchymal  progenitors  with  hematopoietic  features, 
which  extends  the  traditional  understanding  about 
the biology of MSC system. 
P B M M P s   n e e d   T   l y m phocytes  to  support  their 
growth and proliferation, which is similar to CD14+ 
cell-derived  progenitor-l i k e   C F s .   A b e   e t   a l   c o n f i r m  
CFs’ outgrowth requires cellular interaction between 
CD14+ cells and other peripheral blood cells ,   a n d   T  
lymphocytes is necessary f o r   t h e   c u l t u r e   [ 5 ] . However, 
o u r   r e s u l t s   s h o w e d   t h e   o u t g r o w t h   o f   P B M M P s   w a s  
partly inhibited by CD14+ c e l l s .   O n l y   w h e n   C D 1 4 - cell 
f r a c t i o n   i n c r e a s e d   m o r e   t h a n   4   t i m e s   o f   t h a t   i n   n o r m a l  
condition was the clone formation obviously observed 
in  the  mixed  culture. Although the cell density for 
seeding  probably  influences  the  clone  formation, 
sparsely distributed cells were not observed after 7 
days  of  culture.  These  results  indicate  the  direct 
cell-cell interaction plays a more important role than 
the paracrine effect in inhibiting the differentiation of 
CD14-  cell-derived  population.  We  speculate  this 
mechanism may remain a homeostasis in peripheral 
blood that a little mesenchymal population circulates 
under  normal  condition,  and  only  when  monocytes 
are  cons u m e d   i n   t h e   r e g e n e r a t i o n   a n d   r e p a i r   c a n  
M S C s   p r o l i f e r a t e .   O n   t h e   o t h e r   h a n d ,   l a r g e   a m o u n t s   o f  
lymphocytes  migrate  to  the  wound  stimulating  the 
mobilization and  proliferation  of  CD14- cell-derived 
population, which may cause disinhibition from rela-
tively low number of monocytes and MSCs’ prolife-
ration to participate in the healing process. 
CD14+  cell-derived  population  also  shows  the 
s i m i l a r   c h a r a c t e r s   t o   C F s ,   w h i c h   h a s   b e e n   identified 
by Bucala et al in 1994 [4]. They share the same fea-
tures  of  proliferating slowly, passaging difficultly in 
the absence of growth factor support, differentiating 
into  macrophage-like  cells  in  late  phase,  decreased 
expression  of  CD14,  enhanced  expression  of  CD34 
a n d   r e l a t i v e l y   u n c h a n g e d   e x p r e s s i o n   o f   C D 4 5   d u r i n g  
culture, as well as the capabilities of osteogenesis and 
a d i p o g e n e s i s   ( u n p u b l i s h e d   d a t a ) .   T h i s   i s   t h e   f i r s t  
evidence on monocyte-derived progenitors existing in 
r a t   p e r i p h e r a l   b l o o d .   S t u d i e s   h a v e   s h o w n   t h a t   m o n o-
cyte-derived multipotential cells (MOMC) can used as 
a source of mesenchymal and endothelial progenitors 
[17,18] and pluripotent  stem  cells  can  be  generated 
f r o m   a   s u b s e t   o f   peripheral  blood  monocytes  after 
treatment with a high dose of M-CSF [19], which con-
firm that monocytes are not  only phagocyte precur-
sors but multipotent precursors for several lineages, 
including non-hematopoietic cells. We also found the 
differences  between  CD14+  and  CD14-  cell-derived 
populations herein and the differences in the expres-
s i o n s   o f   h e m a t o p o i e t i c   m a r k e r s   C D 1 4   a n d   C D 4 5   r e-
veal  the  origins  from  different  bone  marrow  com-
partments. Also, the apparently different morphology 
implies their origin. The former are cells of fusiform 
w i t h   a   s l i g h t l y   p l u m p   b o d y   a n d   t w o   e l o n g a t e d   t h i n  
ends, whereas the latter are more blanket-like, that is, 
stretched out in shape, pale in color, and without two 
sharp ends. 
Although the mixed culture was a hybrid system 
including PBMMPs, lymphocytes and CD14+ mono-
cyte-derived  population,  the  characteristics  of  pas-
saging difficultly and proliferating slowly in the latter 
p o p u l a t i o n   d e t e r m i n e   t h e i r   m i n o r   r o l e   i n   c u l t u r e   s y s-
tem, and o n   t h e   c o n t r a r y ,   P B M M P s   a r e   t h e   p r e d o m i-
n a n t   p o p u l a t i o n   i n   t h e   m i x e d   c u l t u r e .   E x c e p t   f o r   t h e  
CD45 expression, which has a similar importance to 
CD4, CD8b and   C D 2 6 ,   w e   s p e c u l a t e   t h e   h e m a t o p o i e-
tic  characters  of  cultured  PBMMPs  are 
CD14-/CD34+/CD45-/CD90+.  Together  with  the 
stromal  morphology,  similar  phenotypes  to 
BM-M S C s ,   P B M M P s   a r e   i n d i c a t e d   a s   a   n o v e l   C D 1 4 - 
mesenchymal population with hematopoietic features 
i n   t h e   p e r i p h e r a l   b l o o d   a n d   d e r i v e d   f r o m   b o n e   m a r-
row mesenchymal cells.  
A c t u a l l y ,   B M S C s   c o n s i s t   o f   h e t e r o g e n e o u s   p o p-
u l a t i o n s   o f   s t e m   c e l l s .   R e s u l t s   s h o w e d   s o m e   p u r i f i e d  
B M S C s ,   a l s o   k n o w n   a s   B M -M S C s ,   d i d   n o t   e x p r e s s  
C D 1 4 ,   C D 3 4   a n d   C D 4 5   a n d   b u t   h i g h l y   e x p r e ssed 
CD29, CD73 and CD90. In addition, some BMSCs that 
mixed with hematopoietic cells had low expressions 
o f   C D 1 4 ,   C D 3 4   a n d   C D 4 5 .   T h e   c h a n g e   i n   C D 4 5   e x-
p r e s s i o n   w a s   i n   c o n s i s t e n t   w i t h   C D 1 4 ,   a n d   C D 3 4   r e-
mained at the initial level. It is unlikely that these 
CD14+  progenitors  in  the  marrow  stroma  generate 
PBMMPs and the low CD45 expression also does not 
support the PBMMP’s origin from hematopoietic cells 
including monocytes. 
A l t h o u g h   C D 3 4   w a s   s t i l l   c o n s i d e r e d   t o   b e   a  
marker of primitive hematopoietic stem cells, its ex-
pression doesn’t   r e m a i n   s t a b l e .   S i m i l a r   t o   t h i s ,   C D 1 4  
expression  decreased  during  their  differentiation 
from monocytes to other progenitors. However, the 
C D 4 5   e x p r e s s i o n   w a s   s t a b l e .   O u r   r e s u l t s   c o n f i r m e d  
the alteration of CD34 expression indicating the ma-
t u r a t i o n   o f   P B M M P s   a f t e r   l e a v i n g   t h e   b l o o d   a n d   i m-
planting in the local environment in the way similar to 
that of CD14+ monocytes-derived progenitor such as Int. J. Med. Sci. 2011, 8 
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C F s ,   a n d   l o w   e x p r e s s i o n   o f   C D 4 5   s u g g e s t e d   P B M M P s  
of mesenchymal lineage and high expression of CD45 
confirmed CFs of hematopoietic lineage. Considering 
the high CD34 expression in mesencymal progenitors, 
w e   i n v e s t i g a t e d   t h e   p r e s e n t   o f   c o m m o n   h e m a t o p o i e-
tic-mesenchymal  progenitors.  A  progenitor  origin 
from hematopoietic or mesenchymal lineage can not 
be confirmed only by detection of CD34 expression, 
and then CD45 was used as a more appropriate indi-
cator to define the hematopoietic lineage. 
Another  interesting  finding  is  that  CD34 +  pro-
genitors participate in the regeneration of epithelial 
cells in the skin epidermis. Wu et al have reported that 
implanted CD34+ b o n e   m a r r o w   c e l l s   d i d   n o t   e x p r e s s  
cytokeratin  and  not  incorporate  into  the  epidermis 
and  appendages  in  the  wound [20]. They  indicated 
that BM-M S C s   b u t   n o t   C D 3 4 + cells could generate the 
cutaneous structures. Similarly, a previous study by 
Spees et al proved that  BM-MSCs could repair the epi-
thelial cells in vitro through differentiation and fusion 
[21].  However,  the  homeostasis  in  normal  skin  is 
identical  t o   t h a t   i n   p e r i p h e r a l   b l o o d   a n d   C D 3 4   e x-
pression was also recognized in the epidermal stem 
cells and hair follicle stem cells, which suggests that 
progenitors  with  hematopoieitc features can regene-
rate  the  epidermal  cells  during  the  wound  healing. 
Our  results  provide  evidence  that  CD34+  mesen-
chymal progenitors, but probably not hematopoietic 
originated CD34+ progenitors, play roles in the epi-
dermal  regeneration.  We  have  confirmed  the  epi-
thelial differentiation of these cells into cells in epi-
dermis,  sebaceous  gland  and  hair  follicle  (unpub-
lished data). 
This  study  emphasizes  the  difference  between 
PBMMPs and monocyte-derived progenitors, the si-
milarity  between  PBMMPs  and  BMSCs,  suggesting 
P B M M P s   a s   a   k i n d   o f   c o m m o n   h e m a t o p o i e-
tic-mesenchymal  progenitors.  But  the  physiological 
and pathological functio n s   s h o u l d   b e   f u r t h e r   s t u d i e d  
in  further  experiments.  Although  osteogenesis  and 
adipogenesis indicate their mesenchymal differentia-
tion potential, the characteristic of CD34+ facilitates us 
to  study  their  potential  to  differentiate  into  neural 
cells, cardiac  muscle  cells,  endothelial  cells,  etc,  and 
even to reconstitute lymphohematopoietic system. 
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